$109 Million is the total value of HealthInvest Partners AB's 15 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 53.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $13,591,000 | +44.8% | 538,241 | +41.8% | 12.52% | +79.3% |
| ANIK | Sell | ANIKA THERAPEUTICS INC | $8,615,000 | -11.5% | 175,967 | -13.5% | 7.94% | +9.5% |
| CAH | Sell | CARDINAL HEALTH INC | $8,478,000 | -52.7% | 117,800 | -49.0% | 7.81% | -41.5% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $8,466,000 | -14.4% | 111,112 | -6.3% | 7.80% | +6.0% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $8,366,000 | -51.1% | 107,000 | -49.5% | 7.71% | -39.5% |
| TARO | Sell | TARO PHARMACEUTICAL INDS LTD | $8,306,000 | -11.8% | 78,905 | -7.4% | 7.65% | +9.2% |
| ANTM | Sell | ANTHEM INC | $8,094,000 | -52.5% | 56,300 | -58.6% | 7.46% | -41.2% |
| GILD | New | GILEAD SCIENCES INC | $8,092,000 | – | 113,000 | +100.0% | 7.46% | – |
| MRK | Sell | MERCK & CO INC | $8,012,000 | -18.3% | 136,100 | -13.4% | 7.38% | +1.2% |
| MCK | New | MCKESSON CORP | $8,006,000 | – | 57,000 | +100.0% | 7.38% | – |
| GTS | Sell | TRIPLE-S MGMT CORPcl b | $7,538,000 | -20.0% | 364,156 | -15.3% | 6.94% | -1.0% |
| ELOS | New | SYNERON MEDICAL LTD | $5,931,000 | – | 706,107 | +100.0% | 5.46% | – |
| GNCIQ | Sell | GNC HLDGS INC | $4,669,000 | -52.7% | 422,955 | -12.4% | 4.30% | -41.4% |
| ATEC | New | ALPHATEC HOLDINGS INC | $1,370,000 | – | 426,855 | +100.0% | 1.26% | – |
| ICCC | IMMUCELL CORP | $1,002,000 | -23.0% | 168,323 | 0.0% | 0.92% | -4.6% | |
| SHY | Exit | ISHARES TR1-3 yr tr bd etf | $0 | – | -10,000 | -100.0% | -0.63% | – |
| BIL | Exit | SPDR SERIES TRUSTbrclys 1-3mt etf | $0 | – | -20,000 | -100.0% | -0.68% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -280,000 | -100.0% | -1.32% | – |
| INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -222,875 | -100.0% | -7.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-01-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.